Pseudomonas aeruginosa is a leading cause of chronic respiratory infections in people with
cystic fibrosis (CF), bronchiectasis or chronic obstructive pulmonary disease (COPD), and …

Antibacterial resistance is a renewed public health plague in modern times, and the COVID-
19 pandemic has rekindled this problem. Changes in antibiotic prescribing behavior …

Pseudomonas aeruginosa is a leading cause of nosocomial infections worldwide and
notorious for its broad-spectrum resistance to antibiotics. A key mechanism that provides …

Pseudomonas aeruginosa is the most important opportunistic pathogen leading to serious
and life-threatening infections, especially in immunocompromised patients. Because of its …

Opportunistic pathogens such as Pseudomonas aeruginosa adapt their genomes rapidly
during chronic infections. Understanding their epigenetic regulation may provide biomarkers …

As one of a series of thematically linked reviews of the primary pharmacology of the β-
lactam/β-lactamase inhibitor combination, ceftazidime/avibactam, this article reviews the …

The rising issue of antibiotic resistance has made treating Pseudomonas aeruginosa
infections increasingly challenging. Therefore, vaccines have emerged as a viable …

Methods This study applied SMRT technology to sequence a clinical strain P. aeruginosa
PA3 to obtain its genome sequence and methylation modification information. Genomic …

Pseudomonas aeruginosa is one of the leading causes of nosocomial infections,
characterized by increasing antibiotic resistance, severity and mortality. Therefore …

Pseudomonas aeruginosa (P. aeruginosa) with multi-drug resistance (MDR) is a major
cause of serious healthcare-associated infections, leading to high morbidity and mortality …